Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology and Therapeutics
|
January 3, 2013
Response to "The link between pharmacodynamics and physiologically based pharmacokinetic models"
A Rostami-Hodjegan
Clinical Pharmacology and Therapeutics
|
May 31, 2012
Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology
A Rostami-Hodjegan
Journal of Pharmaceutical Sciences
|
January 10, 1998
Is Cmax/AUC useful for bioequivalence testing?
A Rostami-Hodjegan, G T Tucker
British Journal of Clinical Pharmacology
|
March 22, 2001
Journal impact factors: a 'bioequivalence' issue?
A Rostami-Hodjegan, G T Tucker
Hormone Research
|
November 16, 2005
Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia
R J M Ross, A Rostami-Hodjegan
British Journal of Clinical Pharmacology
|
September 1, 1995
The accumulation of mercaptopurine metabolites in age fractionated red blood cells
A Rostami-Hodjegan, L Lennard, J S Lilleyman
CPT: Pharmacometrics & Systems Pharmacology
|
July 31, 2015
Physiologically Based Pharmacokinetics Is Impacting Drug Development and Regulatory Decision Making
M Rowland, L J Lesko, A Rostami-Hodjegan
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 31, 2007
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment
K Venkatakrishnan, R S Obach, A Rostami-Hodjegan
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
February 27, 2004
Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
N J Proctor, G T Tucker, A Rostami-Hodjegan
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 16, 1999
Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues
G T Tucker, A Rostami-Hodjegan, P R Jackson
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology and Therapeutics
|
January 3, 2013
Response to "The link between pharmacodynamics and physiologically based pharmacokinetic models"
A Rostami-Hodjegan
Clinical Pharmacology and Therapeutics
|
May 31, 2012
Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology
A Rostami-Hodjegan
Journal of Pharmaceutical Sciences
|
January 10, 1998
Is Cmax/AUC useful for bioequivalence testing?
A Rostami-Hodjegan, G T Tucker
British Journal of Clinical Pharmacology
|
March 22, 2001
Journal impact factors: a 'bioequivalence' issue?
A Rostami-Hodjegan, G T Tucker
Hormone Research
|
November 16, 2005
Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia
R J M Ross, A Rostami-Hodjegan
British Journal of Clinical Pharmacology
|
September 1, 1995
The accumulation of mercaptopurine metabolites in age fractionated red blood cells
A Rostami-Hodjegan, L Lennard, J S Lilleyman
CPT: Pharmacometrics & Systems Pharmacology
|
July 31, 2015
Physiologically Based Pharmacokinetics Is Impacting Drug Development and Regulatory Decision Making
M Rowland, L J Lesko, A Rostami-Hodjegan
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 31, 2007
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment
K Venkatakrishnan, R S Obach, A Rostami-Hodjegan
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
February 27, 2004
Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
N J Proctor, G T Tucker, A Rostami-Hodjegan
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 16, 1999
Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues
G T Tucker, A Rostami-Hodjegan, P R Jackson
Page
of 8